AR and neoplasm: Although endocrine therapies have not been contemplated for TNBC treatment, in previous studies, it has been observed that this tumor subtype is capable of secreting steroid hormones and, together with the presence of AR and ERβ, could be an indicator that endocrine therapies may influence on tumor development [23,24].